Article
Gene Therapy Targeting the Inner Retina Rescues the Retinal Phenotype in a Mouse Model of CLN3 Batten Disease.
Human gene therapy - 1 Jul 2020
Kleine Holthaus Sophia-Martha, Aristorena Mikel, Maswood Ryea, Semenyuk Olha, Hoke Justin, Hare Aura, Smith Alexander J, Mole Sara E, Ali Robin R
Abstract excerpt
The neuronal ceroid lipofuscinoses (NCLs), often referred to as Batten disease, are inherited lysosomal storage disorders that represent the most common neurodegeneration during childhood. Symptoms include seizures, vision loss, motor and cognitive decline, and premature death. The development of brain-directed treatments for NCLs has made noteworthy progress in recent years. Clinical trials are currently ongoing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
